Chemgenex Pharmaceuticals Ltd (Other) (6-K)
01 10월 2007 - 11:41PM
Edgar (US Regulatory)
FORM
6-K
U.S.
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES
EXCHANGE ACT OF 1934
dated
October 1, 2007
Commission
File Number 0-51373
CHEMGENEX PHARMACEUTICALS LIMITED
(Exact Name as
Specified in its Charter)
N/A
(Translation of
Registrants Name)
Pigdons Road
Waurn Ponds
P.O. Box 1069, Grovedale
Victoria 3216 Australia
(Address of
principal executive offices)
Indicate by check
mark whether the registrant files or will file annual reports under cover of
Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
o
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1):
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7):
Indicate by check
mark whether by furnishing the information contained in this Form, the
registrant is also thereby furnishing the information to the Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
o
No
x
If Yes is marked,
indicate below the file number assigned to the registrant in connection with
Rule 12g3-2(b): Not applicable.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused the Report to be signed on its behalf by the undersigned, thereunto duly
authorized.
Date: October 1, 2007
|
CHEMGENEX PHARMACEUTICALS
LIMITED
|
|
|
|
|
|
By:
|
/s/ Greg R. Collier
|
|
|
Name:
|
Greg R. Collier
|
|
Title:
|
Managing Director
|
|
|
|
|
|
2
EXHIBIT INDEX
Exhibit
|
|
Description
|
99.1
|
|
Press release, October 1, 2007
|
3
Chemgenex (NASDAQ:CXSP)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Chemgenex (NASDAQ:CXSP)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Chemgenex Pharmaceuticals Ltd (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Chemgenex Pharmaceuticals Ltd News Articles